Introduction to the Global AMR Action Plan

Similar documents
WHO initiatives to build global AMR surveillance capacity

State of Health In EU: Community Pharmacy Contribution

Highlighting in the WHO European Region: Summary. No. 21(February 2012)

Highlighting in the WHO European Region:

Alcohol-related harm in Europe and the WHO policy response

European status report on alcohol and health Leadership, awareness and commitment

GAVI in the WHO European Region: results, current status and future

State of Health In EU: Community Pharmacy Contribution

Progress in Flour Fortification in Central and Eastern Europe and Commonwealth of Independent States

Highlighting in the WHO European Region: measles outbreaks rubella surveillance acute flaccid paralysis surveillance

Analysis of 3-dose oral/inactivated poliovirus vaccine (OPV3/IPV3) immunization coverage

Information about activities in the region of possible relevance for the regional strategic plan. GF-TADs for Europe

SDG 2: Target 3.7: Indicators Definitions, Metadata, Trends, Differentials, and Challenges

Gender Statistics Programme of the United Nations Economic Commission for Europe

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%

The cancer burden in the European Union and the European Region: the current situation and a way forward

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA

Summary. Primary care data. Week 49/2014. Season

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON

Reflecting on ten years of progress in the fight against AIDS, TB and malaria

Hepatitis C in the WHO European Region

European Status report on Alcohol and Health

Seventh GF-TADs for Europe Steering Committee meeting (RSC7)

Priorities for achieving Millennium Development Goals (MDGs) 4 and 5 in the European Region

Situation update in the European Region: overview of influenza surveillance data week 40/2009 to week 07/2010.

Lumpy skin disease follow-up project proposal

Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia

Current Situation on Avian Influenza and the pandemic threat

Lumpy skin disease (LSD) Vaccination Data Collection

Childhood TB and new TB drugs in the WHO European Region

EURO POLIO PAGE Data as of 04 October 2005 (Week 38)

The European Neighbourhood Policy (ENP) ENP Coordination External Relations Directorate General European Commission

Total Market Approach to Improving Family Planning Access in the Republic of Georgia

TB/HIV in the WHO European Region Overview, Priorities & Response

Lumpy skin disease (LSD) Epidemiological situation in Europe (update since LSD4)

Nutrition, diet and health in the WHO European Region Progress and opportunities for further action to achieve SDGs by 2030

Southeast European Center for Surveillance and Control of Infectious Diseases (SECID)

The challenge of obesity in the WHO European Region

Welcome to the new EURO Immunization Monitor

The State of Measles and Rubella in the WHO European Region

GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE

Noncommunicable diseases progress monitoring. Are we meeting the time-bound United Nations targets?

World Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006

Achieving the United Nations 2030 Sustainable Development Goals, Health 2020 and the SEE 2020 goals: how to make it happen?

AMR SURVEILLANCE IN THE REPUBLIC OF BELARUS

Epidemiological trends of TB in Eastern Europe TB and migration

Çeşme Izmir, Turkey, September 2013

Progress in maternal and child health: Uzbekistan and WHO European Region

Better Health for All in Latvia

Issue No. 6, December 2012

Lumpy skin disease (LSD) Epidemiological situation in Europe (update since LSD2)

Animal health situation of OIE Member Countries in Europe 1 st semester 2012 (and previous)

May 26-28, 2010, Almaty, Kazakhstan November 2011

Poliomyelitis eradication in the WHO European Region

Lumpy skin disease (LSD) & Sheep Pox. State of play in the EU

Monitoring noncommunicable disease commitments in Europe Theme in focus: progress monitor indicators

WHO Meeting on Strengthening measles and rubella laboratory network in the Russian Federation and Newly Independent States

Global, regional and national strategic planning for viral hepatitis prevention and control

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe

Establishment of networks of human and animal virology laboratories and medical entomology

THE FUND TO END VIOLENCE AGAINST CHILDREN Working toward a world in which every child grows up free from violence

Eliminating measles and rubella and preventing congenital rubella infection

Prevention and control of hepatitis B and C in the European Region of WHO

Report of the 26th Meeting of the European Regional Certification Commission for Poliomyelitis Eradication

MediLabSecure. Maria Grazia Dente and Silvia Declich National Center for Global Health Istituto Superiore di Sanità

Comparative analysis of nutrition policies in the WHO European Region

Progress Towards Global Polio Eradication by 2012: Progress and Ongoing Challenges

Updates from the European Centre for Disease Prevention and Control

Upgrade of the EPIS-FWD system: Concept and concrete features

PREPERATION OF TURKEY TO EFSA ACTIVITIES

Access to HCV treatment in Europe

Introducing. the WHO Regional Office for Europe

Comparative Analysis of Nutrition Policies in WHO European Member States

Tenth meeting of the European Technical Advisory Group of Experts on Immunization: Outcomes and recommendations

New Delhi International Ministerial Conference on Avian and Pandemic Influenza Dec 4-6th, 2007

Issue No. 9, December 2013

National Institute for Health and Welfare (THL) Protecting health and welfare in Finland

Towards a Sustainable Global Infrastructure for Medical Countermeasures

WHO meeting on strengthening the measles and rubella laboratory network in the Russian Federation and newly independent states

Measles and rubella monitoring January 2015

4th meeting of the European Technical Advisory Group of Experts for Immunization (ETAGE) Copenhagen, Denmark, June 2005

Economic and Social Council

Regional Committee for Europe Fifty-second session

Social determinants of health: outcome of the World Conference on Social Determinants of Health (Rio de Janeiro, Brazil, October 2011)

Budapest, Hungary, September 2017 xx July xxx. Progress reports

Gender equality DGNEAR

The WHO Global Project on anti-tb drug resistance surveillance: background, objectives, achievements, challenges, next steps

Where we stand in EFORT

67 Years of Leadership in Pharmacy. A Journey of Continuous Improvement

Using Data For Decision Making

Media Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences

ABORTION IN EASTERN AND CENTRAL EUROPEAN COUNTRIES: LEGAL AND ETHICAL ASPECTS

Key issues for HIV testing and

United Nations Office on Drugs and Crime (UNODC)

Fifth report of Committee A

Implementing the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2010 Progress Report SPECIAL REPORT.

Injuries in Europe: a call for public health action An update from 2008 WHO Global Burden of Disease

31 May to 2 June 2016 // Copenhagen, Denmark. 30th Meeting of the European Regional Certification Commission for Poliomyelitis Eradication

Copenhagen, Denmark, September August Malaria

European Patients Academy on Therapeutic Innovation

Transcription:

Introduction to the Global AMR Action Plan Dr Danilo Lo Fo Wong Programme Manager Antimicrobial Resistance

Antibiotic resistance WHO meetings, consultations, workshops in 1971, 1977, 1981, 1982, 1994, 1996, 1997, 1998, 1999, 2002, 2004, 2008, 2009 World Health Assembly resolutions in 1986, 1988, 1990, 1992, 1994, 1996, 1998, 2001, 2005, 2007, 2009 WHO global strategy for containment of antimicrobial resistance published in 2001 Despite progress, strategies for containment not widely implemented

Renewed global efforts Centralized secretariat at WHO HQ (December 2011) WHO Global AMR Task Force AMR Strategic and Technical Advisory Group (STAG) High-level awareness raising, e.g. World Health Assembly AMR Side Events 2012 hosted by Sweden, Ghana 2013 hosted by Sweden, UK 2014 hosted by Netherlands, UK and Turkey

Global AMR Action Plan Resolution adopted at World Health Assembly (May 2014) Call for Global Action Plan by WHA 2015 Stakeholder and public engagement Technical consultations AMR surveillance (Dec 12, Mar 14, Sep 14) STAG (Sept 13, Apr 14, Oct 14, Feb 15)

Global AMR Action Plan Online consultation 4 July to 1 September 2014 Contributions from MS, NGOs, Private, Academia, Int Organizations High-level ministerial meetings Netherlands (June 2014) Norway (Nov 2014) Sweden (Dec 2014) Submit to World Health Assembly 2015

Global AMR Action Plan

Guiding principles Whole-of-society engagement Actions based on best available knowledge and evidence Prevention first Access not excess Sustainability Incremental targets for implementation

Five strategic objectives: 1. Improve awareness and understanding 2. Strengthen the knowledge and evidence base 3. Reduce the incidence of infection 4. Optimize the use of antimicrobial medicines 5. Develop the economic case for sustainable investment

Framework for action http://apps.who.int/gb/ebwha/pdf_files/wha68/a68_20-en.pdf

Implementing, monitoring and evaluation Countries to develop and implement national action plans building blocks National priorities, circumstances WHO to develop monitoring & evaluation framework Reporting every 2 years Other stakeholders to develop own action plans and report within normal reporting cycle

European strategic action plan on antibiotic resistance (2011 2016) WHO European action plan adopted by all 53 Member States Recognizing AMR neglected in many countries of the region No systematic AMR surveillance in large part of the Region Need for intersectoral coordination International spread through travel and trade Need for international standards and data sharing

Action Plan Strategic Objectives 1. Strengthen intersectoral coordination 2. Strengthen surveillance of antibiotic resistance 3. Promote rational use and strengthen surveillance of antibiotic consumption 4. Strengthen infection prevention and control and surveillance in health care settings 5. Prevent emerging resistance in veterinary and food sectors 6. Promote innovation and research on new drugs 7. Improve awareness, patient safety, and partnership

Implementation activities Country situation analysis Albania, Armenia, Azerbaijan, Belarus, Bosnia and Herzegovina, Georgia, Kyrgyzstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan National AMR workshops Belarus, The former Yugoslav Republic of Macedonia, Georgia, Moldova, Serbia, Turkey, Uzbekistan International AMR workshops November 2013, Bilthoven, The Netherlands July 2014, Tbilisi, Georgia February 2015, Copenhagen, Denmark

Expanding AMR surveillance throughout Europe European Antimicrobial Resistance Surveillance Network (EARS-Net) Central Asian and eastern European Surveillance of Antimicrobial Resistance (CAESAR) European Centre for Disease Prevention and Control World Health Organization Regional Office for Europe Countries submitting data to CAESAR Countries visited for CAESAR 9th participation EURL-AR Workshop 2015 Countries to be visited for CAESAR participation Countries participating in EARS-Net

Expanding AM use surveillance throughout Europe European Surveillance of Antimicrobial Consumption Network (ESAC-Net) WHO/Europe-ESAC Project Group European Centre for Disease Prevention and Control World Health Organization Regional Office for Europe Countries which reported 2011 data to WHO Countries in the process of collecting 9th EURL-AR data Workshop 2015 Countries invited to join Countries participating in ESAC-Net

Infection prevention and control SAVE LIVES: Clean Your Hands - WHO's global annual campaign 2014 link to AMR

AMR in the food chain Booklet: AMR from a food safety perspective National workshops Albania, Tajikistan, Uzbekistan, Turkmenistan Subregional workshops Balkans (Albania), Central Asia (Kazakhstan) Advisory Group on Integrated Surveillance of AMR (AGISAR) World Health Day 7 April 2015

Awareness day Materials: Infograph Website Video Press release Presentation Activities Country events (press conferences, seminars) EC/ECDC/WHO twitter chat

Campaign support Call for proposals (April 2014) Template, SMART objectives, selection criteria Proposal review (May 2014) Panel of expert partners (WHO, RIVM, ECDC, BAPCOC) Grants awarded (ARM, BIH, GEO, KGZ, MKD, MNE, SRB) Implementation June 2014 to February 2015 Workshop (February 2015) Exchange experiences and expertise

Partnership

Acknowledgments Division of Communicable Disease, Health Security & Environment Guenael Rodier Cristiana Salvi Siff Malue Nielsen AMR Coordination Danilo Lo Fo Wong Nienke van de Sande-Bruinsma Saskia Nahrgang Food Safety Hilde Kruse Health Systems and Public Health Hans Kluge Health Technologies and Pharmaceuticals Hanne Bak Pedersen Nina Sautenkova Influenza & other Respiratory Pathogens Caroline Brown Vaccine Preventable Diseases & Immunization Robb Butler Catharina de Kat-Reynen Alert and Response Operations Ana Paula Coutinho

No action today No cure tomorrow Thank you for your attention